Apotea AB (publ) (CHIX:APOTES) Other Operating Expense: kr1,729 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
18 GF Score
Price kr65.20
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Other Operating Expense?

Apotea AB (publ) CHIX:APOTES 18 Other Operating Expense is kr1,729 Mil as of Jun. 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Other Operating Expense for the three months ended in Jun. 2026 was kr453 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr1,729 Mil.

Apotea AB (publ)'s quarterly Other Operating Expense increased from Dec. 2025 (kr435 Mil) to Mar. 2026 (kr448 Mil) and increased from Mar. 2026 (kr448 Mil) to Jun. 2026 (kr453 Mil).

Apotea AB (publ)'s annual Other Operating Expense increased from Dec. 2023 (kr1,336 Mil) to Dec. 2024 (kr1,525 Mil) and increased from Dec. 2024 (kr1,525 Mil) to Dec. 2025 (kr1,634 Mil).

Apotea AB (publ) Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Other Operating Expense Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
1,060.80 1,222.40 1,336.10 1,525.30 1,633.90

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 417.70 392.90 434.60 447.60 453.40
CHIX:APOTES
18GF Score
Apotea AB (publ) CHIX:APOTES
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,729 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr1,729 Mil mean?
Apotea AB (publ) (CHIX:APOTES) has a Other Operating Expense of kr1,729 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Other Operating Expense too high?
Apotea AB (publ)'s current Other Operating Expense is kr1,729 Mil. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Other Operating Expense compare to competitors?
Apotea AB (publ)'s Other Operating Expense of kr1,729 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Other Operating Expense is kr1,729 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Other Operating Expense of kr1,729 Mil. The current Other Operating Expense is kr1,729 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Other Operating Expense is kr1,729 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for CHIX:APOTES

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr65.20
Price